Skip to content

Clinical trials

Completed Observational Metabolic Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Metabolic Diseases Phase: Observational Status: Completed Clear all

75 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20041
20051
20062
20072
20081
20091
20102
20123
20137
20145
20151
20167
20174
20184
20197
20205
20215
20224
20238
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed75

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Messina4
Chinese Medical Association3
Hacettepe University2
Massachusetts General Hospital2
20Lighter1
AdventHealth Translational Research Institute1
Alexion Pharmaceuticals, Inc.1
Alnylam Pharmaceuticals1
Amicus Therapeutics1
Azienda Sanitaria-Universitaria Integrata di Udine1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Metabolic Diseases75
Diabetes Mellitus12
Cardiovascular Diseases10
Obesity10
Genetic Diseases, Inborn8
Diabetes Mellitus, Type 26
Endocrine System Diseases6
Insulin Resistance6
Autoimmune Diseases4
Critical Illness4

Trials

Showing 1 to 25 of 75. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.